From the beginning, the goal was always to build a more predictive model of human physiology.
The pioneering work on Organ-Chips was begun by our founding team at the Wyss Institute for Biologically Inspired Engineering at Harvard University. Following the landmark paper in Science, “Reconstituting Organ-Level Lung Functions on a Chip,” Emulate was founded to share the success of these efforts with the broader life sciences community. Since our inception, we have been focused on delivering exceptional science across multiple organs and applications.

In 2019, Emulate researchers published a pivotal paper in Science Translational Medicine demonstrating how the mechanisms of drug-induced liver injury can be dissected using the Emulate Liver-Chip. Today, Emulate counts 18 of the top 20 pharmaceutical companies as customers, including leading academic and government entities around the globe. And we’re just getting started.

Emulate Videos

Drug Testing Shake Up with Organs-on-a-Chip - Video